APPLICATIONS PUBLISHED 7 AUGUST 2002
Published: 1-Feb-2003
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Dental materials with nano-sized silica particles
3M Innovative Properties Company 1227781*
Oral compsns providing optimal surface conditioning
Procter & Gamble 1227787*
Improved stannous oral compsns
Procter & Gamble 1227788*
Improved dual phase stannous oral compsns
Procter & Gamble 1227789*
Use of aromatic polycyclic compounds as activators of PPARS-type receptors in a cosmetic or pharmaceutical compsn
L'Oreal 1227791*
Cyclosporin formulation
Cipla 1227793*
Method for encapsulating proteins or peptides in liposomes produced using said method, and their use
Novosom 1227794*
Lipid complex of alkylcyclines
Pharmacia Italia 1227795*
Solid dispersion pharmaceutical formulations
Abbott Laboratories 1227797*
Controlled release hydrocodone formulations
Euro-Celtique 1227798*
A film, sheet or wafer-shaped administration
LTS Lohmann Therapie-Systeme 1227799*
Osmotic controlled release drug delivery device
Merck 1227800*
Multi-layer preparation in film form, consisting of hydrophobic polymers, for the rapid release or active ingredients
LTS Lohmann Therapie-Systeme 1227801*
Film preparation for biphasic release of pharmacologically active or other substances
LTS Lohmann Therapie-Systeme 1227802*
Methods and compounds for inhibiting amyloid deposits
Queen's University at Kingston; Neurochem 1227803*
Use of an aldosterone antagonist for treating restenosis
Pharmacia 1227804*
Mediators of hedgehog signalling pathways, compsns and uses related thereto
Curis 1227805*
Pharmaceutical formulation containing tolterodine and its use
Pharmacia 1227806*
Irrigation solution and method for inhibition of pain and inflammation
Omeros Corp 1227807*
Use of treosulfan for patient conditioning before bone marrow or blood stem cell transplantation
Medac Gesellschaft fuer klinische Spezialpraeparate 1227808*
Heteroatom-interrupted analogues of 15-hydroxyeicosatetraenoic acid and methods of use
Alcon Universal 1227809*
Treating cancer by increasing intracellular malonyl CoA levels
Johns Hopkins University School of Medicine 1227810*
Use of 2-imidazolyl substituted carbinols for production of a medicament for treatment or prophylaxis of disease states as a result of ischaemic conditions
Aventis Pharma Deutschland 1227811*
Topical nasal treatment using desloratadine
Schering 1227812*
Reverse-turn mimetics and methods relating thereto
Molecumetics 1227813*
Hormonal compsn based on a progesterone and an oestrogen and use thereof
Laboratoire Theramex 1227814*
Contraceptive medicament based on a progesterone and an oestrogen and method for producing the same
Laboratoire Theramex 1227815*
Cholesterol lowering and blood lipids lowering compsn
Triple Crown Aktiebolag 1227816*
Ciclesonide-containing aqueous pharmaceutical compsn
Byk Gulden Lomberg Chemische Fabrik 1227817*
ABC1 modulation for the modulation of cholesterol transport
Wisconsin Alumni Research Foundation 1227818*
Inhibiting FTSZ protein (De)-polymerisation
Institute for Molecular Cell Biology, Universiteit van Amsterdam; Institute for Molecular Chemistry, Universiteit van Amsterdam 1227819*
Oligosaccharide aldonic acid and their topical use
Yu, Reuy; van Scott, Eugene 1227820*
Therapeutic compsns and methods of use thereof
Hodosh, Milton 1227821*
Methods for restoring or enhancing T-cell image immune surveillance following naturally or artificially induced immunosuppression
XCyte Therapies 1227822*
Methods of inducing in vivo proliferation and migration of transplanted progenitor cells in the brain
Stem Cells 1227823*
Transplant/implant device and method for its production
Sulzer Orthopedics 1227824*
Isolation and expansion of human marrow stromal cells
Philadelphia Health and Education Corp 1227825*
Compsn comprising an extract of Perna canaliculus, methylsulphonylmethane and glucosamine
Foodscience 1227826*
Lactic acid bacteria for the treatment and/or prophylaxis for giardiasis
Societe des Produits Nestle 1227827*
Viruses for the treatment of cellular proliferative disorders
Oncolytics Biotech 1227828*
Novel chimeric analgesic peptides
New England Medical Centre Hospital 1227829*
Method of inducing angiogenesis
Cornell Research Foundation 1227830*
Interferon gamma for the treatment of asthma
Mondobiotech 1227831*
Methods of treating short stature disorders related to the short stature homeobox-containing (Shox) gene
Rappold-Hoerbrand, Gudrun 1227832*
Plasminogen-like polynucleosides, polypeptides and antibodies
Human Genome Sciences 1227833*
Use of caspase-14 and caspase-14 modulators to diagnose and/or treat skin, eye and brain disorders
Vlaams Interuniversitair Institute voor Biotechnologie vzw 1227834*
Protease inhibitors as modulators of periodontal wound healing
Biotech Australia; The University of Queensland, Department of Dentistry 1227835*
Treatment of intermediate and high-grade non-Hodgkins lymphoma with anti-CD20 antibody
Idec Pharmaceuticals 1227836*
Method of inducing and/or enhancing an immune response to tumour antigens
Aventis Pasteur 1227837*
Melanoma vaccine and methods of making and using same
St Vincent's Hospital and Medical Centre of New York 1227838*
Live bacterial vaccines against Escherichia coli 0157:H7
National Research Council of Canada 1227839*
Adjuvanted genetic vaccines
Powderject Vaccines 1227840*
A novel method of diagnosing, monitoring, staging, imaging and treating cancer
Diadexus 1227841*
Inhibition of angiogenesis by antibodies against high molecular weight kinnogen domain 5
Temple University of the Commonwealth System of Higher Education 1227842*
Method and system to remove cytokine inhibitor in patients
Lentz, M Rigdon 1227843*
Compsns for treating atheroma and neoplastic tissue
Pharmacyclics; The Board of Regents, The University of Texas Systems 1227844*
Mixture containing rare earths and use thereof
Forschungszentrum Karlsruhe 1227845*
Methods for inhibiting neurofibromatosis type 1 (NF1)
Advanced Research and Technology Institute; Clapp, Wade; Ingram, David; Marshall, Mark 1227846*
Inhibitors of the endothelin signalling pathway and alphaVbeta3 integrin receptor antagonists for combination therapy
BASF 1227847*
Method for linking molecular substances
ACGT Progenomics 1227848*
Novel hydronaphthalene compounds, prepared by a rhodium catalysed ring opening reaction in the presence of phosphine ligand
AstraZeneca 1228024*
A method for solvent-free hydrodebromination in the presence of aromatic carboxylic acids
Mossi & Ghisolfi Overseas 1228025*
Hydroxyeicosatetraenoate salts, compsns and methods of use in treating dry eye disorders
Alcon Universal 1228028*
Hydroxyeicosatetraenoic acid analogues and methods of their use in treating dry eye disorders
Alcon Universal 1228029*
Benzenoid derivatives of 15-hydroxyeicosatetraenoic acid and methods of their use in treating dry eye disorders
Alcon Universal 1228030*
Omega chain modified 15-hydroxyeicosatetraenoic acid derivatives and methods of their use in treating dry eye disorders
Alcon Universal 1228031*
Compsns containing hydroxyeicosatetraenoic acid derivatives and methods of their use in treating dry eye disorders
Alcon Universal 1228032*
Preparing method of chiral ester
Samsung Fine Chemicals; Pohang University of Science and Technology Foundation 1228033*
Chiral phosphines, transition complexes thereof and uses thereof in asymmetric reaction
The Penn State Research Foundation 1228034*
Compounds having MIF antagonist activity
The Picower Institute for Medical Research 1228037*
N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
Aventis Pharma Deutschland 1228039*
